Trials / Terminated
TerminatedNCT00471120
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Dick Domanik · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at developing an accurate, simple, and cost-effective method for screening and early detection of uterine cancers
Detailed description
The present study aims at developing an accurate, simple and cost-effective method for screening and early detection of uterine cancers in women using novel inventions and biotechnology methods for collection and assay of uterine cells. Results of P2X7 assays using tissues obtained from women with known uterine cancer and from women with histologically normal endometrium will be compared. These data will also serve as basis for future studies to test the predictive value of the method in population-based studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | P2x7 assay | compare P2X7 assay to biopsy |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-04-01
- Completion
- 2008-02-01
- First posted
- 2007-05-09
- Last updated
- 2015-08-05
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00471120. Inclusion in this directory is not an endorsement.